Barrigel
Barrigel, by Palette Life Sciences, is an injectable biodegradable rectal spacer that separates the prostate from the rectum to protect it during radiation therapy treatment for prostate cancer. Barrigel is made from Non-Animal Stabilized Hyaluronic Acid (NASHA®), which has been proven safe and effective, and has been used for more than 20 years in over 50 million medical procedures worldwide. A groundbreaking spacing technology, it is the first and only hyaluronic acid, visually-guided, sculptable spacer, for patients undergoing radiotherapy treatment for prostate cancer. Learn more at Barrigel.com.
Boston Scientific
Boston Scientific partners with physicians to continually advance the quality of patient care with innovative solutions so you can choose the right technology and the right technique for every patient – without compromise. Visit our booth and speak with a representative to learn more.
Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.
IsoAid
As the manufacturer of Advantage™ I-125 and Pd-103 seeds for over 20 years, IsoAid specializes in providing Brachytherapy seeds for the treatment of prostate, ocular and breast cancer, as well as for diagnostic localization purposes. We are a full-service company you can always rely on, making seeds at the activity you request, custom-loading and delivering them faster than anyone in the industry. Through our exclusive partnership with Eye Physics we give you access to cutting edge eye plaques and planning services, which deliver many clinical advantages to you and your patients. High-activity seeds are custom-loaded using COMS or Eye Physics plaques. Our innovate Secure Strand™ cuts down significantly on seed migration for prostate patients and is now being used for RSL with great success. Our team of experts is dedicated to helping with every aspect of your program and is happy to serve as a complete resource for you. IsoAid is invested in the future of Brachytherapy and we look forward to introducing you to some exciting new advances very soon.
IsoRay
IsoRay develops innovative, targeted, personalized brachytherapy products that effectively treat many forms of cancer. IsoRay's proprietary isotope, Cesium Blu, has over 10 years of proven patient outcomes for the treatment of prostate cancer. Learn how one little seed is redefining modern brachytherapy at www.isoray.com.
Theragenics
An industry pioneer & leader, Theragenics Celebrates 40 Years of Forward Thinking in the global supply of LDR brachytherapy seeds for the treatment of prostate cancer, intra-ocular malignancies, and other tumor types with radiosensitivity. To learn more about our industry benchmark recognized sources, TheraSeed® Pd-103 & AgX100® I-125, please visit www.theragenics.com.
Varian
Imagine a world free from the fear of cancer. We do, every day. That’s why at Varian, a Siemens Healthineers Company, we’re obsessed with creating simpler, more efficient, and more effective technologies to power new victories in cancer care. From afterloaders to applicators, and a range of software tools for planning LDR and HDR brachytherapy treatments, Varian technology helps you give your patients the treatments they need, exactly where they need it. To learn more about our solutions, go to http://www.varian.com.
Best Medical International, Inc.
For more than 40 years, Best Medical has served the medical community with the highest quality products and unparalleled customer service. Our brachytherapy (Iodine/Pd/Iridium/Gold) seeds, gold fiducial markers, supplies, accessories (needles, templates, applicators, catheters) and other products exemplify our commitment to uncompromised quality and safety. Best Medical International now encompasses a family of trusted companies and organizations with a proven track record of innovation, quality and service in external beam radiation therapy, brachytherapy and vascular brachytherapy solutions. Our aim is to be the one partner that clinicians turn to for all their radiotherapy and oncology product and service requirements.
BK Medical systems
BK Medical's systems integrate with leading brachytherapy seed planning software to enable precise ultrasound guidance. Our biplane transducer delivers exceptional images in the sagittal and transverse view, which provides better orientation during needle placement and source placement in the prostate gland. Please visit https://www.bkmedical.com/ for more information
CivaTech Oncology
For over 15 years, CivaTech Oncology has been developing and delivering the most innovative, groundbreaking products to improve care and outcomes using brachytherapy. Our platforms can deliver higher doses with less toxicities, broadening the spectrum of opportunity for improved cancer therapy. Come visit our booth and learn about the many varieties of homogenous, shielded, and customized products including the commercially available CivaDerm™ bandage for non-melanoma skin diseases. Empowering the surgical and radiation oncology teams to aggressively destroy cancer!
AccuCARE by CIVCO
AccuCARE by CIVCO Medical Solutions is a complete line of prostate treatment equipment and accessories designed for several ultrasound-guided transperineal or transrectal procedures such as brachytherapy, fiducial marker placement, template-guided biopsies, and cryotherapy. The AccuCARE line offers clinicians a range of equipment, including stabilizers that provide a secure, multi-directional base and steppers for real-time and pre-planned procedures. Visit CIVCO.com to learn more.
MIM Software Inc.
MIM Software Inc. offers a powerful combination of tools available for:
The MIM Software advantage comprises a complete pathway solution for prostate cancer and breast cancer management. Please visit https://www.mimsoftware.com/ for prostate fusion and LDR products and http://www.breastmicroseed.com/ for Concure Oncology.
Qfix
Qfix has a rich history of discovering, developing and commercializing technology-driven solutions for radiotherapy patient positioning. Our revolutionary Symphony® Brachytherapy Solution supports lithotomy positioning and is designed to maximize workflow efficiencies by seamlessly aiding in the setup, insertion, imaging, transfer and treatment. Thanks to the patent pending AirDrive™ technology, Symphony® can transfer to a wide variety of surfaces including surgical tables, stretchers, and beds as well as CT and MR scanners.
Alpha Tau Medical
Alpha Tau Medical develops and commercialize the Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), an innovative technology that enables the highly potent and uniquely conformal alpha-irradiation of solid tumors. The treatment is delivered by intratumoral insertion of radionuclide Radium-224, which leads to the release and diffusion of daughter radioisotopes that emit alpha particles. These alpha particles have the capacity to destroy solid tumors. Since the alpha-emitting atoms diffuse only a short distance in tissue, Alpha DaRT mainly damages the tumor, while sparing the healthy tissue around it.
BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
NeuroLogica
NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., is a global leader in the field of point-of-care computed tomography (CT) imaging. NeuroLogica develops, manufactures, and markets all CT scanners from our headquarters in Danvers, Massachusetts. Our advanced medical technologies are used worldwide in leading healthcare institutions, helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency.
Orfit
Orfit brings high precision and comfort to the positioning and immobilization of cancer patients in Radiation Oncology. The Zephyr HDR system utilizes patented hover technology to allow patient transfer from procedure to imaging to treatment while maintaining patient positioning and minimizing the risk of needle/applicator displacement. Integrating Zephyr HDR for your brachytherapy procedures allows the incorporation of valuable 3D dosimetric data from CT/MR imaging, providing more accuracy in today’s brachytherapy procedures. Visit www.orfit.com for more information.
Adaptiiv Medical Technologies Inc.
Adaptiiv Medical Technologies Inc. provides practitioners with regulatory cleared software that enables the design and 3D printing of patient-specific HDR brachytherapy applicators for use in radiation therapy. Applicators are customized using Adaptiiv software and conform to complex patient anatomy, improving the quality of treatment and accuracy and dose delivery. Clinics have greater access to providing personalized care and improved workflow efficiency such as reduced setup and production times. Adaptiiv software has FDA 510(k) clearance, CE Mark, ISO 13485 certification, and TGA (Australia) approval.
C4 Imaging
C4 Imaging develops innovative medical devices that enable clinicians to personalize patient care through accurate image-guided procedures. The company's core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that has been encapsulated within a variety of implantable, biocompatible shells.
GT Medical Technologies, Inc.
Driven to overcome the limitations of current treatments for brain tumors and raise the standard of care, a team of brain tumor specialists joined forces and formed GT Medical Technologies with the purpose of improving the lives of patients with brain tumors. Its GammaTile Therapy received FDA 510(k) regulatory clearance for the treatment of all types of recurrent brain tumors and newly diagnosed malignant tumors. 3D, resorbable collagen tiles, embedded with radiation sources, are implanted during the last five minutes of brain tumor resection procedures, providing an immediate, dose-intense treatment to eliminate residual tumor cells. This "one and done" procedure allows patients to receive their course of radiation while going about their daily lives, requiring no additional trips to the hospital or clinic for radiation therapy.
CIRS
CIRS, part of Sun Nuclear, is recognized worldwide for tissue simulation technology and is the leader in the manufacture of phantoms and simulators for quantitative densitometry, calibration, quality control and research in the field of medical imaging and radiotherapy. For over 35 years, CIRS has been simulating a wide variety of tissues by blending epoxy resins, urethanes, water-based polymers and other proprietary materials. Many of our tissue equivalent phantoms are market leaders or unique in their categories.
Merit Medical
The innovative strut-based, open-architecture design of the SAVI® Brachy applicator combines the precise dosimetry of interstitial brachytherapy with the ease and convenience of single-entry devices. With SAVI Brachy, patients receive customized radiation therapy based on their specific anatomy. SAVI Brachy uses thin tubes (catheters) to deliver radiation directly to the lumpectomy site. The catheters gently expand to fit the size and shape of the tumor cavity. A tiny radiation seed travels through each catheter to deliver a precise dose of radiation, customized for the exact size, shape or location of the target tissue. The SAVI Brachy applicator is gently inserted in a closed position into the tumor cavity through a small incision, a procedure that is usually done in the physician’s office. The catheters are gently expanded to conform to the shape of the cavity. This is done only once, at the beginning of treatment. Once the catheter is in place, a radiation oncologist delivers treatment twice a day for 2-5 days. The ends of the catheters are connected to a computerized delivery system that painlessly delivers a tiny radioactive seed into each tube. The radiation source is completely removed after each treatment – no radiation remains in the body between treatments. After the last radiation treatment, the physician will close the device and remove it through the same incision into which it was originally inserted.
Myovant
We aspire to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Our purpose is resolute and fueled by the opportunity to improve the lives of millions of women and men, many impacted by diseases during their most productive years of life. Despite the significant burden of common diseases like uterine fibroids, endometriosis, and prostate cancer, many women and men do not have the options they deserve and need.
RadCalc
Increase confidence in your patient treatment plan QA process while gaining efficiency with RadCalc intelligent automation QA workflows. Our Brachytherapy module computes an independent 3D dose map to QA against your treatment planning system. With DVH analysis and Gamma evaluation tools and point dose reporting. RadCalc, a product of the LAP Group, is your gold standard in HDR, LDR and Permanent Implant patient QA. Visit us at RadCalc.com.
RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. Brachytherapy planning was added to RayStation®* in 2021,further expanding the TPS offering, with unique features and composite planning tools.
More information is available at raysearchlabs.com.
* Subject to regulatory clearance in some markets.
Veracyte
The Decipher Prostate Genomic Classifier by Veracyte provides prognostic information to assess patients' individual risk. It has been validated in over 60 studies as the most accurate predictor of metastasis, prostate cancer-specific mortality, and overall survival.
